MXPA03010181A - Polipeptidos de citocinas. - Google Patents

Polipeptidos de citocinas.

Info

Publication number
MXPA03010181A
MXPA03010181A MXPA03010181A MXPA03010181A MXPA03010181A MX PA03010181 A MXPA03010181 A MX PA03010181A MX PA03010181 A MXPA03010181 A MX PA03010181A MX PA03010181 A MXPA03010181 A MX PA03010181A MX PA03010181 A MXPA03010181 A MX PA03010181A
Authority
MX
Mexico
Prior art keywords
methods
polypeptides
imx129840
cytokine
cytokine polypeptides
Prior art date
Application number
MXPA03010181A
Other languages
English (en)
Spanish (es)
Inventor
Peter R Baum
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Publication of MXPA03010181A publication Critical patent/MXPA03010181A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MXPA03010181A 2001-05-10 2002-05-08 Polipeptidos de citocinas. MXPA03010181A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29023901P 2001-05-10 2001-05-10
PCT/US2002/014587 WO2002092762A2 (en) 2001-05-10 2002-05-08 Cytokine polypeptides

Publications (1)

Publication Number Publication Date
MXPA03010181A true MXPA03010181A (es) 2004-03-16

Family

ID=23115104

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03010181A MXPA03010181A (es) 2001-05-10 2002-05-08 Polipeptidos de citocinas.

Country Status (8)

Country Link
US (2) US20030104579A1 (OSRAM)
EP (1) EP1412499A4 (OSRAM)
JP (1) JP2004535795A (OSRAM)
AU (1) AU2002314774B2 (OSRAM)
CA (1) CA2446180A1 (OSRAM)
MX (1) MXPA03010181A (OSRAM)
PL (1) PL373008A1 (OSRAM)
WO (1) WO2002092762A2 (OSRAM)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6927040B2 (en) 2000-06-30 2005-08-09 Zymogenetics, Inc. Interferon-like protein Zcyto21
US7038032B2 (en) 2001-04-20 2006-05-02 Zymogenetics, Inc. Cytokine protein family
US7910313B2 (en) 2001-04-20 2011-03-22 Zymogenetics, Inc. Cytokine protein family
ES2311622T3 (es) * 2001-04-20 2009-02-16 Zymogenetics, Inc. Familia proteica de citoquinas.
AU2003215136A1 (en) 2002-02-08 2003-09-02 University Of Medicine And Dentistry Of New Jersey Ifn-a/b-independent mechanism of antiviral protection
EP1575609A4 (en) 2002-10-23 2010-12-15 Zymogenetics L L C METHOD FOR THE TREATMENT OF VIRUS INFECTIONS USING IL-28 AND IL-29
WO2005023862A2 (en) 2003-08-07 2005-03-17 Zymogenetics, Inc. Homogeneous preparations of il-28 and il-29
US20050244423A1 (en) 2004-04-02 2005-11-03 Klucher Kevin M Methods for treating viral infection using IL-28 and IL-29 cysteine mutants
WO2006012644A2 (en) * 2004-07-29 2006-02-02 Zymogenetics, Inc. Use of il-28 and il-29 to treat cancer
US8158129B2 (en) * 2005-04-06 2012-04-17 Ibc Pharmaceuticals, Inc. Dimeric alpha interferon PEGylated site-specifically shows enhanced and prolonged efficacy in vivo
JP4987001B2 (ja) 2005-07-20 2012-07-25 ザイモジェネティクス リミテッド ライアビリティ カンパニー 癌および自己免疫障害を処置するためのｉｌ２８およびｉｌ２９の短縮型システイン変異体の使用法
EP2922870B1 (en) * 2012-11-21 2019-08-07 The Governors of the University of Alberta Immunomodulatory peptides and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6927040B2 (en) * 2000-06-30 2005-08-09 Zymogenetics, Inc. Interferon-like protein Zcyto21
US6822082B2 (en) * 2000-06-30 2004-11-23 Zymogenetics, Inc. Polynucleotides for mammalian secreted protein, Z1055G2P

Also Published As

Publication number Publication date
US20030104579A1 (en) 2003-06-05
WO2002092762A3 (en) 2004-03-04
US20070081973A1 (en) 2007-04-12
PL373008A1 (en) 2005-08-08
AU2002314774B2 (en) 2007-06-28
EP1412499A4 (en) 2005-04-06
CA2446180A1 (en) 2002-11-21
JP2004535795A (ja) 2004-12-02
WO2002092762A2 (en) 2002-11-21
EP1412499A2 (en) 2004-04-28

Similar Documents

Publication Publication Date Title
MXPA03010181A (es) Polipeptidos de citocinas.
ATE286053T1 (de) Naphthyridinone zur hemmung der durch protein- tyrosin-kinase und zellzyklus kinase hervorgerufenen zellvermehrung
ATE485366T1 (de) Verwendung von lysyloxydase inhibitoren zur zellkultur und gewebeaufbau
ATE252113T1 (de) Verwendung von wnt polypeptiden
WO2002102997A3 (en) Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same
SG152273A1 (en) Pdx1 expressing endoderm
UA81398C2 (en) Keratinocytes which may be used as biologically active substances for the treatment of wounds
WO2005020921A3 (en) C-kit modulators and methods of use
MY125594A (en) Immortalized cell lines for virus growth
GB2394723A (en) Culture system for rapid expansion of human embryonic stem cells
WO2003060082A3 (en) Use of modified pyrimidine compounds to promote stem cell migration and proliferation
PL356846A1 (en) Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase
TNSN07028A1 (en) Fused ring heterocycle kinase modulators
DK1650307T3 (da) Fremgangsmåde til fremstilling af rekombinante proteiner ved anvendelse af apoptoseinhibitorer
EP0559769A4 (en) Heparin binding mitogen with homology to epidermal growth factor (egf)
PL374312A1 (en) Endothelial stem cells, populations, methods of isolation and use thereof
WO2004066966A3 (en) Peptide yy analogs
WO2004029200A3 (en) Method of enhancing proliferation and/or hematopoietic differentiation of stem cells
WO2003010291A3 (en) Treatment of immune disorders and b cell disorders
ATE363531T1 (de) Claudin polypeptide
Fuchigami et al. Fibroblasts promote the collective invasion of ameloblastoma tumor cells in a 3D coculture model
WO2021226439A8 (en) Engineered relaxins and methods of use thereof
IL149416A0 (en) Human enzymes of the metalloprotease family
DE50211985D1 (de) Verwendung von pyridin-2,4-dicarbons urediamiden und pyrimid in-4,6-dicarbons urediamiden zur selektiven inhibierung von kollagenasen
WO2021041592A8 (en) Methods of treating vascular diseases